RCMI Coordinating Center (RCMI CC) Header Logo

Psychomotor agitation and hyperactive delirium in COVID-19 patients treated with aripiprazole 9.75 mg/1.3 ml immediate release.

Martinotti G, Barlati S, Prestia D, Palumbo C, Giordani M, Cuomo A, Miuli A, Paladini C, Amore M, Bondi E, Vita A, Fagiolini A, Di Giannantonio M. Psychomotor agitation and hyperactive delirium in COVID-19 patients treated with aripiprazole 9.75 mg/1.3 ml immediate release. Psychopharmacology (Berl). 2020 11; 237(11):3497-3501.

View in: PubMed

RCMI CC is supported by the National Institute on Minority Health and Health Disparities, National Institutes of Health (NIH), through Grant Number U24MD015970. The contents of this site are solely the responsibility of the authors and do not necessarily represent the official views of the NIH

For technical support please contact support